Atypical antipsychotics for insomnia: a systematic review
- 1 June 2016
- journal article
- review article
- Published by Elsevier in Sleep Medicine
- Vol. 22, 13-17
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Effects of extended-release quetiapine fumarate on long-term functioning and sleep quality in patients with Generalized Anxiety Disorder (GAD): Data from a randomized-withdrawal, placebo-controlled maintenance studyJournal of Affective Disorders, 2013
- Evaluation of adjunct extended-release quetiapine fumarate on sleep disturbance and quality in patients with major depressive disorder and an inadequate response to on-going antidepressant therapyInternational Journal of Neuropsychopharmacology, 2013
- Long-term functioning and sleep quality in patients with major depressive disorder treated with extended-release quetiapine fumarateInternational Clinical Psychopharmacology, 2012
- What Is the Role of Sedating Antidepressants, Antipsychotics, and Anticonvulsants in the Management of Insomnia?Current Psychiatry Reports, 2012
- Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorderNeuropsychiatric Disease and Treatment, 2012
- GRADE guidelines: 3. Rating the quality of evidenceJournal of Clinical Epidemiology, 2011
- Metabolic Consequences of Using Low-Dose Quetiapine for Insomnia in Psychiatric PatientsCommunity Mental Health Journal, 2009
- Quetiapine in primary insomnia: a pilot studyPsychopharmacology, 2007
- Atypical antipsychotics in bipolar disorder: systematic review of randomised trialsBMC Psychiatry, 2007
- Adjunctive risperidone treatment and sleep symptoms in combat veterans with chronic PTSDDepression and Anxiety, 2006